CanSino Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SHSC:6185 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
18 Dec 24	BuyHK$558,000	Shou-Bai Chao	Individual	18,000	HK$31.00
27 Nov 24	BuyHK$823,080	Xuefeng Yu	Individual	30,000	HK$27.44
26 Sep 24	BuyHK$436,050	Xuefeng Yu	Individual	20,000	HK$21.80
09 Sep 24	BuyHK$367,356	Xuefeng Yu	Individual	20,000	HK$18.37
09 Sep 24	BuyHK$549,600	Shou-Bai Chao	Individual	30,000	HK$18.32
25 Jul 24	BuyHK$18,180	Jing Wang	Individual	1,000	HK$18.18
24 Jul 24	BuyHK$185,704	Xuefeng Yu	Individual	10,000	HK$18.57
24 Jul 24	BuyHK$129,120	Jing Wang	Individual	7,000	HK$18.45
15 Jul 24	BuyHK$56,880	Jing Wang	Individual	3,000	HK$18.96
12 Jul 24	BuyHK$292,212	Shou-Bai Chao	Individual	15,000	HK$19.48
10 Jul 24	BuyHK$93,731	Shou-Bai Chao	Individual	5,000	HK$18.75
09 Jul 24	BuyHK$377,160	Xuefeng Yu	Individual	20,000	HK$18.86
09 Jul 24	BuyHK$145,548	Jing Wang	Individual	7,800	HK$18.66

Insider Trading Volume

Insider Buying: 6185 insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 6185?
Owner Type	Number of Shares	Ownership Percentage
Employee Share Scheme	277,650	0.112%
Private Companies	7,516,538	3.04%
Institutions	25,607,917	10.4%
Individual Insiders	70,453,942	28.5%
General Public	143,187,754	58%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 41.32% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.28%	Xuefeng Yu	17,974,200	HK$821.8m	-39.1%	no data
7.27%	Tao Zhu	17,962,400	HK$821.2m	0%	no data
6.94%	Dongxu Qiu	17,134,400	HK$783.4m	-39.3%	no data
6.61%	Huihua Mao	16,334,200	HK$746.8m	-39.8%	no data
3.04%	Qm29 Limited	7,516,538	HK$343.7m	0%	no data
1.95%	Goldman Sachs Group, Investment Banking and Securities Investments	4,809,877	HK$219.9m	0%	0.01%
1.54%	The Vanguard Group, Inc.	3,804,623	HK$173.9m	0.79%	no data
1.17%	SDIC Innovation Investment Management Co., Ltd.	2,883,810	HK$131.8m	0%	1.46%
0.7%	JPMorgan Chase & Co, Brokerage and Securities Investments	1,732,962	HK$79.2m	0%	no data
0.62%	GF Fund Management Co., Ltd.	1,534,311	HK$70.1m	0%	0.01%
0.6%	Bosera Asset Management Co., Ltd.	1,490,170	HK$68.1m	0%	0.02%
0.58%	BlackRock, Inc.	1,442,163	HK$65.9m	2.07%	no data
0.56%	Barclays PLC Private Banking & Investment Banking Investment	1,395,072	HK$63.8m	0%	0.01%
0.52%	China Merchants Fund Management Company Ltd.	1,291,998	HK$59.1m	0%	0.05%
0.36%	Capital Research and Management Company	900,919	HK$41.2m	0%	no data
0.34%	Yinhua Fund Management Co., Ltd.	848,680	HK$38.8m	0%	0.04%
0.27%	Zhongqi Shao	675,000	HK$30.9m	0%	no data
0.19%	Enterprise Annuity Plan of Industrial and Commercial Bank of China Co., Ltd	465,025	HK$21.3m	0%	2.5%
0.16%	Dimensional Fund Advisors LP	399,793	HK$18.3m	0%	no data
0.12%	First Trust Advisors LP	289,136	HK$13.2m	0%	no data
0.11%	Cansino Biologics Inc., ESOP	277,650	HK$12.7m	0%	no data
0.11%	China Southern Asset Management Co., Ltd.	269,027	HK$12.3m	0%	no data
0.097%	Zhong Ou Fund Management Co., Ltd	240,600	HK$11.0m	0%	no data
0.088%	Fullgoal Fund Management Co. Ltd.	216,176	HK$9.9m	0%	no data
0.076%	China Asset Management Co. Ltd.	188,787	HK$8.6m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/27 18:18
End of Day Share Price	2024/12/27 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CanSino Biologics Inc. is covered by 19 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Bo Li	BofA Global Research
Lijian Zhao	China International Capital Corporation Limited
Hangci Zheng	China International Capital Corporation Limited